Ignite Creation Date:
2025-12-25 @ 4:12 AM
Ignite Modification Date:
2025-12-26 @ 3:11 AM
Study NCT ID:
NCT00267020
Status:
COMPLETED
Last Update Posted:
2020-08-31
First Post:
2005-12-16
Is NOT Gene Therapy:
False
Has Adverse Events:
True
Brief Title:
Phase 2 Study of Gemcitabine or Gemcitabine + Enzastaurin in Participants With Advanced or Metastatic Pancreatic Cancer
Sponsor:
Eli Lilly and Company
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2005-12
Start Date Type:
None
Primary Completion Date:
2008-05
Primary Completion Date Type:
ACTUAL
Completion Date:
2008-05
Completion Date Type:
ACTUAL
First Submit Date:
2005-12-16
First Submit QC Date:
None
Study First Post Date:
2005-12-20
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2020-06-09
Results First Submit QC Date:
None
Results First Post Date:
2020-08-31
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
2009-10-07
Disp First Post Date Type:
ESTIMATED
Last Update Submit Date:
2020-08-17
Last Update Post Date:
2020-08-31
Last Update Post Date Type:
ACTUAL